Sheffield Institute for Translational Neuroscience SITraN is an essential development in the fight against motor neurone disease, other common neurodegenerative disorders, stroke and neuroinflammatory conditions. You are here Home Sheffield Institute for Translational Neuroscience Photo of Queen Elizabeth II visiting SITraN in 2010 About SITraN Our impact Our research Study with us Facilities News 29 June 2023 AI tool could speed up dementia diagnosis A new AI tool that could help doctors assess the early signs of dementia and Alzheimer’s more quickly and efficiently, has been developed by researchers at the University of Sheffield. 21 June 2023 Sheffield-developed HeadUp Collar wins award for patient driven research A cross-organisation collaboration led by The University of Sheffield has been awarded for the development of an innovative neck collar designed for people affected by MND; the first ever global award celebrating excellence in patient engagement. 21 June 2023 New programme to move potential MND drugs into clinical trials faster A ground-breaking experimental medicine programme that will enable researchers to more rapidly screen potential drugs in people with motor neuron disease (MND) has been announced today (21 June 2023) on MND Awareness Day. NIHR Sheffield Biomedical Research Centre 28 April 2023 FDA approves drug which helps to slow progression of rare form of MND The Food and Drug Administration (FDA) in the US has authorised the first approved drug for a rare form of motor neurone disease (MND) based on the results of a Phase 3 clinical trial completed at the University of Sheffield. View all SITraN news
